HRES-359-119
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsored by Brittany Pettersen (D-CO)
What it does
This resolution would express congressional support for the mission and goals of National Fentanyl Awareness Day in 2025. It would call attention to the dangers of fake or counterfeit fentanyl pills, particularly their impact on families and young people. As a simple resolution (H.Res.), it would not create law, appropriate funds, or impose any legal requirements on any person or entity.
Who benefits
Public health advocates and organizations focused on opioid awareness who gain a congressional endorsement for their messaging. Families affected by fentanyl-related overdoses who may see increased public attention on the issue. Young people who may be reached by awareness campaigns that receive a boost from congressional recognition. Drug prevention educators and community organizations whose work is amplified by the resolution's visibility.
Who is hurt
No group faces a direct material harm from this resolution, as it carries no legal force, spending, or regulatory effect. Opponents of federal involvement in drug messaging — whether on cost, effectiveness, or policy grounds — may object to the implicit endorsement of a particular public health framing, but face no tangible burden.
Supporters argue
Supporters argue that fentanyl is now the leading cause of death for Americans aged 18–45, with the CDC reporting over 70,000 fentanyl-involved overdose deaths in a single year, and that counterfeit pills disguised as prescription medications are a primary vector of accidental exposure among young people. They contend that congressional recognition of a dedicated awareness day amplifies public health messaging at no cost, helping prevention organizations reach broader audiences and potentially saving lives.
Opponents argue
Opponents argue that symbolic resolutions consume legislative time and resources without producing measurable outcomes, and that the opioid crisis demands substantive policy action — such as funding for treatment, interdiction, or harm reduction — rather than non-binding declarations. They contend that awareness campaigns alone have shown limited effectiveness in reducing overdose rates, and that congressional energy would be better directed toward enforceable legislation addressing the supply chain of illicit fentanyl.